Roel Bakker
Roel Bakker
modeller of infectious disease epidemics, London School of Hygiene and Tropical Medicine
Geverifieerd e-mailadres voor lshtm.ac.uk
Titel
Geciteerd door
Geciteerd door
Jaar
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical …
JW Eaton, NA Menzies, J Stover, V Cambiano, L Chindelevitch, A Cori, ...
The Lancet Global Health 2 (1), e23-e34, 2014
2042014
Determinants of the impact of sexually transmitted infection treatment on prevention of HIV infection: a synthesis of evidence from the Mwanza, Rakai, and Masaka intervention …
EL Korenromp, RG White, KK Orroth, R Bakker, A Kamali, D Serwadda, ...
The Journal of infectious diseases 191 (Supplement_1), S168-S178, 2005
1702005
HIV and aging--preparing for the challenges ahead
MD Till Bärnighausen, JN MIA
The New England journal of medicine 366 (14), 1270, 2012
1542012
The impact of antiretroviral treatment on the age composition of the HIV epidemic in sub-Saharan Africa
JAC Hontelez, SJ de Vlas, R Baltussen, ML Newell, R Bakker, F Tanser, ...
AIDS (London, England) 26 (0 1), 2012
1382012
Elimination of HIV in South Africa through expanded access to antiretroviral therapy: a model comparison study
JAC Hontelez, MN Lurie, T Bärnighausen, R Bakker, R Baltussen, ...
PLoS Med 10 (10), e1001534, 2013
1322013
Proportion of new HIV infections attributable to herpes simplex 2 increases over time: simulations of the changing role of sexually transmitted infections in sub-Saharan …
EE Freeman, KK Orroth, RG White, JR Glynn, R Bakker, MC Boily, ...
Sexually transmitted infections 83 (suppl 1), i17-i24, 2007
1292007
Male circumcision for HIV prevention in sub-Saharan Africa: who, what and when?
RG White, JR Glynn, KK Orroth, EE Freeman, R Bakker, HA Weiss, ...
Aids 22 (14), 1841-1850, 2008
1102008
Can population differences explain the contrasting results of the Mwanza, Rakai, and Masaka HIV/sexually transmitted disease intervention trials?: A modeling study
RG White, KK Orroth, EL Korenromp, R Bakker, M Wambura, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 37 (4), 1500-1513, 2004
1052004
Understanding the differences between contrasting HIV epidemics in east and west Africa: results from a simulation model of the Four Cities Study
KK Orroth, EE Freeman, R Bakker, A Buvé, JR Glynn, MC Boily, RG White, ...
Sexually transmitted infections 83 (suppl 1), i5-i16, 2007
1042007
Ageing with HIV in south africa
JAC Hontelez, MN Lurie, ML Newell, R Bakker, F Tanser, T Bärnighausen, ...
AIDS (London, England) 25 (13), 2011
892011
Treating curable sexually transmitted infections to prevent HIV in Africa: still an effective control strategy?
RG White, KK Orroth, JR Glynn, EE Freeman, R Bakker, JDF Habbema, ...
Journal of acquired immune deficiency syndromes (1999) 47 (3), 346, 2008
872008
HIV dynamics and behaviour change as determinants of the impact of sexually transmitted disease treatment on HIV transmission in the context of the Rakai trial
EL Korenromp, R Bakker, SJ Vlas, RH Gray, MJ Wawer, D Serwadda, ...
Aids 16 (16), 2209-2218, 2002
722002
The impact of the new WHO antiretroviral treatment guidelines on HIV epidemic dynamics and cost in South Africa
JAC Hontelez, SJ De Vlas, F Tanser, R Bakker, T Bärnighausen, ...
PloS one 6 (7), e21919, 2011
702011
Elimination of African onchocerciasis: modeling the impact of increasing the frequency of ivermectin mass treatment
LE Coffeng, WA Stolk, A Hoerauf, D Habbema, R Bakker, AD Hopkins, ...
PloS one 9 (12), e115886, 2014
652014
cAMP-mediated effects of ouabain and theophylline on paracellular ion selectivity
R Bakker, JA Groot
American Journal of Physiology-Gastrointestinal and Liver Physiology 246 (2 …, 1984
621984
Empirical observations underestimate the proportion of human immunodeficiency virus infections attributable to sexually transmitted diseases in the Mwanza and Rakai sexually …
KK Orroth, RG White, EL Korenromp, R Bakker, J Changalucha, ...
Sexually transmitted diseases 33 (9), 536-544, 2006
522006
Population-level effect of potential HSV2 prophylactic vaccines on HIV incidence in sub-Saharan Africa
EE Freeman, RG White, R Bakker, KK Orroth, HA Weiss, A Buvé, ...
Vaccine 27 (6), 940-946, 2009
502009
Concerted efforts to control or eliminate neglected tropical diseases: how much health will be gained?
SJ de Vlas, WA Stolk, EA le Rutte, JAC Hontelez, R Bakker, DJ Blok, ...
PLoS neglected tropical diseases 10 (2), e0004386, 2016
492016
HIV spread and partnership reduction for different patterns of sexual behaviour‐a study with the microsimulation model STDSIM
EL Korenromp, C Van Vliet, R Bakker, SJ de Vlas, JDF Habbema
Mathematical Population Studies 8 (2), 135-173, 2000
442000
The potential impact of RV144-like vaccines in rural South Africa: a study using the STDSIM microsimulation model
JAC Hontelez, N Nagelkerke, T Bärnighausen, R Bakker, F Tanser, ...
Vaccine 29 (36), 6100-6106, 2011
392011
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20